Fig. 2From: Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice modelComparison of subtherapeutic and supratherapeutic VCM starting doses and dosing adjustments in pre and post-implementation phasesBack to article page